Ignite Creation Date:
2025-12-25 @ 5:05 AM
Ignite Modification Date:
2025-12-26 @ 4:07 AM
Study NCT ID:
NCT04423718
Status:
COMPLETED
Last Update Posted:
2025-08-29
First Post:
2020-06-08
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Study of the Effects of High Dose Aflibercept Injected Into the Eye of Patients With an Age-related Disorder That Causes Loss of Vision Due to Growth of Abnormal Blood Vessels at the Back of the Eye
Sponsor:
Bayer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-08-11
Start Date Type:
ACTUAL
Primary Completion Date:
2022-07-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-08-07
Completion Date Type:
ACTUAL
First Submit Date:
2020-06-08
First Submit QC Date:
None
Study First Post Date:
2020-06-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-07-09
Results First Submit QC Date:
None
Results First Post Date:
2023-09-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-06
Last Update Post Date:
2025-08-29
Last Update Post Date Type:
ESTIMATED